Testing the diagnostic accuracy of a 68Ga-PSMA PET Scan in Early Biochemical Recurrence of Prostate Cancer
PET-PSMA is currently used for restaging prostate cancer (pCa) after primary surgery or radiotherapy. The PSA levels beyond which it is useful to perform it, in terms of cost-benefit ratio, are not to date clearly defined.
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Sciendo
2024-10-01
|
| Col·lecció: | Forum of Clinical Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.2478/fco-2023-0034 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|